Abstract
Background: Advanced Parkinson’s disease (PD) therapies offer increasingly diverse ways to control motor complications, but evidence defining comparative sequences and sustainable Gulf Cooperation Council (GCC) delivery remains limited. Objective: To appraise advanced therapies, distinguish established benefit from uncertain positioning, and propose a practical framework for referral, selection and regional implementation. Evidence acquisition: This critical narrative review used targeted retrieval of clinical studies, guidance, regulatory documents and regional sources, with a publication cut-off of 8 November 2026 and revision verification on 9 November and additional citation checks on 12 November 2026. Appraisal addressed comparator, population, endpoint, attrition, treatment burden and applicability. No meta-analysis or formal consensus process was undertaken. Evidence synthesis: Controlled infusion trials generally showed OFF-time differences of approximately 1.4–1.9 hours/day, but heterogeneous comparators and selected populations prevent treatment ranking. Conventional deep brain stimulation has substantial randomised evidence; adaptive systems require algorithm- and patient-specific interpretation. Focused ultrasound demands target-specific assessment of irreversible and cumulative risks. Regional cohorts document selected-centre experience, while national access remains incompletely verified. Cardiometabolic and cognitive vulnerability, language, care-partner capacity, Ramadan medication timing and continuity of funding or support modify implementation. GCC-PD ADVANCE links six decision domains to parallel documentation of clinically preferred and feasible care, explicit escalation and measurable follow-up. Conclusions: Timely evaluation and individualised selection should connect responsive symptoms with acceptable burden and sustainable care. GCC-PD ADVANCE is an author-proposed framework requiring stakeholder refinement and prospective evaluation; it does not establish a validated therapeutic hierarchy.